Analysts believe Anavex Life Sciences Corp. (NASDAQ:AVXL) is worth $15.00 per share

Anavex Life Sciences Corp. (NASDAQ:AVXL) registered a 5.78% increase, still its new closing price is 95.88% up from the company’s 1 year high of 8.30.It posted 14.15% gains in previous 5 sessions and is now the subject of 0 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 0 buy or better ratings. The 1 stock analysts following this company have an average price target at $15.00, with individual PT in the $15.00-$15.00 range. The shares moved at $4.76, implying that brokerage firms see shares gaining about 11.48% in twelve months time.

Anavex Life Sciences Corp. (AVXL) SEC Form 4 News

The stock is getting much attention these days as insiders are adding shares while they posted a 20.20% rise year to date. A President, CEO, CFO, Treasurer at Anavex Life Sciences Corp. (AVXL) acquired shares in a transaction closed on Tuesday July 14, 2015. MISSLING CHRISTOPHER U bought 1,000 shares in the company at $0.52 each and collected $1 in proceeds. MISSLING CHRISTOPHER U now owns 4,013,000 shares in the company after this transaction. A President, CEO, CFO, Treasurer in the company, MISSLING CHRISTOPHER U, disclosed a transaction on Monday July 13, 2015 that ended up paying $1 from the purchase of 1,000 shares at $0.53 per share.

Anavex Life Sciences Corp. (NASDAQ:AVXL) Upcoming Results on Tap

Anavex Life Sciences Corp. will next provide financial results for the September 2017 quarter. Stock analysts expect it to report per-share earnings of $-0.06 in that period. Sales during the quarter are predicted to arrive at $0.

Earnings surprise history: Last quarter, the company posted approximately $0 in revenue and EPS of $-0.06. The mean forecast was for $0 and $-0.09 a share, respectively. One quarter earlier, revenue for the stock was at $0, with earnings at $-0.06/share.

Anavex Life Sciences Corp. (AVXL) Brokerage Update 

Over the last six months and over the last three months, the shares of Anavex Life Sciences Corp. (AVXL), have changed 41.25% and 70.61%, respectively.